These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11690554)

  • 1. Improvements in gene therapy technologies.
    Kaneda Y
    Mol Urol; 2001; 5(2):85-9. PubMed ID: 11690554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel fusogenic viral liposome system (HVJ-liposomes) and its applications to the treatment of acquired diseases.
    Kaneda Y
    Mol Membr Biol; 1999; 16(1):119-22. PubMed ID: 10332746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes.
    Tsujie M; Isaka Y; Nakamura H; Kaneda Y; Imai E; Hori M
    Kidney Int; 2001 Apr; 59(4):1390-6. PubMed ID: 11260400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer.
    Saeki Y; Matsumoto N; Nakano Y; Mori M; Awai K; Kaneda Y
    Hum Gene Ther; 1997 Nov; 8(17):2133-41. PubMed ID: 9414261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
    Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
    Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusigenic viral liposome for gene therapy in cardiovascular diseases.
    Dzau VJ; Mann MJ; Morishita R; Kaneda Y
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11421-5. PubMed ID: 8876150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy using HVJ-liposomes: the best of both worlds?
    Kaneda Y; Saeki Y; Morishita R
    Mol Med Today; 1999 Jul; 5(7):298-303. PubMed ID: 10377521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes.
    Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R
    J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HVJ liposomes and HVJ envelope vectors.
    Kaneda Y
    Cold Spring Harb Protoc; 2011 Oct; 2011(10):1281-9. PubMed ID: 21969614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfection by quantitatively reconstituted Sendai envelope proteins into liposomes.
    Kim HS; Park YS
    Cancer Gene Ther; 2002 Feb; 9(2):173-7. PubMed ID: 11857035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.
    Aoki M; Morishita R; Muraishi A; Moriguchi A; Sugimoto T; Maeda K; Dzau VJ; Kaneda Y; Higaki J; Ogihara T
    J Mol Cell Cardiol; 1997 Mar; 29(3):949-59. PubMed ID: 9152856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy.
    Otomo T; Yamamoto S; Morishita R; Kaneda Y
    J Gene Med; 2001; 3(4):345-52. PubMed ID: 11529664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
    Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system.
    Kaneda Y; Nakajima T; Nishikawa T; Yamamoto S; Ikegami H; Suzuki N; Nakamura H; Morishita R; Kotani H
    Mol Ther; 2002 Aug; 6(2):219-26. PubMed ID: 12161188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of HVJ envelope vector and its application to gene therapy.
    Kaneda Y; Yamamoto S; Nakajima T
    Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HVJ-envelope as an innovative vector system for cardiovascular disease.
    Kotani H; Nakajima T; Lai S; Morishita R; Kaneda Y
    Curr Gene Ther; 2004 Jun; 4(2):183-94. PubMed ID: 15180584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium.
    Yonemitsu Y; Kaneda Y; Muraishi A; Yoshizumi T; Sugimachi K; Sueishi K
    Gene Ther; 1997 Jul; 4(7):631-8. PubMed ID: 9282164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of liposomes and pseudovirions with fusion activity for efficient gene delivery.
    Kaneda Y
    Curr Gene Ther; 2011 Dec; 11(6):434-41. PubMed ID: 22023472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total vascular exclusion safely facilitates liver specific gene transfer by the HVJ (sendai virus)-liposome method in rats.
    Kawashita Y; Fujioka H; Ohtsuru A; Kuroda H; Eguchi S; Kaneda Y; Yamashita S; Kanematsu T
    J Surg Res; 2006 May; 132(1):136-41. PubMed ID: 16337969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kupffer cell targeting by intraportal injection of the HVJ cationic liposome.
    Yoshida M; Yamamoto N; Uehara T; Terao R; Nitta T; Harada N; Hatano E; Iimuro Y; Yamaoka Y
    Eur Surg Res; 2002; 34(3):251-9. PubMed ID: 12077513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.